Company Filing History:
Years Active: 2000
Title: The Innovations of Stephen Nutt
Introduction
Stephen Nutt is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biopharmaceuticals, particularly in the area of glutamate receptors. His work has implications for understanding and treating various neurological conditions.
Latest Patents
Stephen Nutt holds a patent for "Glutamate receptor (or EAA receptor) polynucleotides and their uses." This patent describes human CNS receptor-encoding DNA that can express more than one form of the receptor protein, including both an edited and an unedited form. These forms are functionally distinct and appear to be selectively expressed. The gene subject to such editing has potential value in screening compounds for therapeutic applications.
Career Highlights
Stephen Nutt is associated with Allelix Biopharmaceuticals Inc., where he continues to advance research in the biopharmaceutical sector. His work focuses on the development of innovative solutions for neurological disorders, leveraging his expertise in receptor biology.
Collaborations
Stephen collaborates with Rajender Kamboj, contributing to the advancement of their shared research goals.
Conclusion
Stephen Nutt's innovative work in the field of glutamate receptors showcases his commitment to advancing medical science. His contributions have the potential to lead to significant therapeutic advancements in treating neurological conditions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.